Clinical Studies

Trial Evaluating an Investigational Agent for Management of Oral Melanoma in Dogs - Richmond Location

CURRENTLY ENROLLING

This trial is designed to evaluate the effectiveness of a novel therapy in dogs with oral melanoma.

STUDY DETAILS

Trial Evaluating an Investigational Agent for Management of Oral Melanoma in Dogs - Springfield Location

CURRENTLY ENROLLING

This trial is designed to evaluate the effectiveness of a novel therapy in dogs with oral melanoma.

STUDY DETAILS

Evaluating the Tolerability of Combination of Verdinexor and Doxorubicin in Dogs with Cancer - Richmond Location

CLOSED

Verdinexor is a chemotherapy drug that has been conditionally approved by the FDA for the treatment of canine lymphoma. Verdinexor is a selective inhibitor of nuclear export (SINE) compound, and this family of drug has demonstrated encouraging results in preclinical studies when combined with other chemotherapeutic drugs.

STUDY DETAILS

Trial Evaluating an Investigational Agent for Management of Transitional Cell Carcinoma - Richmond Location

CLOSED

This trial is designed to evaluate the safety and preliminary pain management and anti-cancer effectiveness of a novel therapy in dogs with bladder transitional cell carcinoma (TCC).

STUDY DETAILS